Universitätsspital Zürich (USZ)

Myeloid-derived immunosuppression of chimeric antigen receptor T cells in the neuronal microenvironment of glioblastoma (2026) Zhang J, von Ehr J, Look T, Benotmane JK, Neidert N, Kueckelhaus J, Weiss T, et al. Journal article Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression (2026) Wahnschaffe L, Jungherz D, Müller TA, Pemovska T, Pichler A, Poulain S, Julia E, et al. Journal article AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 Update (2026) Hartkopf A, Albert US, Bartsch R, Bauerfeind I, Banys-Paluchowski M, Bjelic-Radisic V, Blohmer JU, et al. Journal article, Review article Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group (2026) Held F, Bayas A, Christe K, Dettmers C, Domurath B, Ebert J, Faßhauer E, et al. Journal article Protonen- versus Photonenbestrahlung beim Oropharynxkarzinom (2026) Rühle A, Balermpas P, Krause M, Haderlein M, Adeberg S, Hecht M Journal article S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Genetisch-cholestatische Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2026) Hudert CA, Jankofsky M, Keitel-Anselmino V, Krawczyk M, Kremer A, Lammert F, Lurz E, et al. Journal article Translating ctDNA into cutaneous melanoma care: An international expert survey (2026) Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, et al. Journal article Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC–ESTRO OligoCare consortium (2026) Widder J, Bol GM, Simek IM, Ehret F, Abdel-Aty H, Basic S, Chuter D, et al. Journal article, Review article Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database (2026) Käs F, Elhai M, Becker MO, Dobrota R, Mihai C, Sauer G, Tofani L, et al. Journal article The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133) (2026) Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, et al. Journal article